Odiparcil
N/A
Report date: 2026/04/20 20:01:59
NME
Base Information
Drug NameOdiparcil
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[33]
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBiossil IncGlaxosmithkline PlcInventiva Pharma
Active IndicationsN/A
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksN/A